Importantly, mTOR persistently restrains the tumor-suppressive function of 4E-BP1 via phosphorylation thereby releasing 4E‐BPs from eIF4E and enabling cap-dependent translation initiation in cancer [161, 162]. The gene discussed is EIF4E; the disease is cancer.